ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1015 • 2015 ACR/ARHP Annual Meeting

    Contribution of TNF and Type I Interferon to the Development of Persistent Post-Inflammatory Mechanical Allodynia in Arthritic Mice

    Sarah Woller1, Cody Ocheltree2, Tony Yaksh1 and Maripat Corr2, 1Anesthesiology, UCSD, La Jolla, CA, 2Division of Rheumatology, Allergy, and Immunology, UCSD, La Jolla, CA

    Background/Purpose: Male C57Bl/6 (WT) mice develop transient inflammation in response to K/BxN serum transfer and show a corresponding pain state, which persists beyond the resolution…
  • Abstract Number: 1016 • 2015 ACR/ARHP Annual Meeting

    Collagen Antibodies Induce Pain-like Behavior in Mice Independent of Inflammation and Complement Activation but Requires Fcγrs

    Gustaf Wigerblad1, Katalin Sandor1, Kutty Selva Nandakumar2, Rikard Holmdahl3 and Camilla Svensson1, 1Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden, 2Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden, 3Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: Collagen Antibody Induced Arthritis (CAIA) is an acute mouse model of rheumatoid arthritis (RA). It is induced by an intravenous injection of a cocktail…
  • Abstract Number: 1017 • 2015 ACR/ARHP Annual Meeting

    A Novel Mechanism of Arthritis-Induced Pain: Activation of Sensory Neurons By Autoantibodies

    Duygu Bas1, Alex Bersellini Farinotti1, Jon Sinclair2, Gustaf Wigerblad3, Kutty Selva Nandakumar4, Rikard Holmdahl5, Bo Rydqvist2 and Camilla Svensson3, 1Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden, 2Karolinska Institutet, Stockholm, Sweden, 3Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden, 4Department of Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden, 5Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: Joint pain is one of the main reasons for patients with rheumatoid arthritis (RA) to seek medical care. Collagen type II (CII) antibodies (Abs)…
  • Abstract Number: 1018 • 2015 ACR/ARHP Annual Meeting

    A 32-Mer Aggrecan Fragment Generated through Adamts-4/5 and MMP-Mediated Cleavage Can Directly Excite Nociceptive Neurons

    Rachel E. Miller1, Richard J. Miller2, Abdelhak Belmadani3, Suzanne Golub4, Amanda J. Fosang4 and Anne-Marie Malfait5, 1Biochemistry, Rush University Medical Center, Chicago, IL, 2Molecular Biochemistry and Pharmacology, Northwestern University, Chicago, IL, 3Northwestern University, Chicago, IL, 4University of Melbourne, Melbourne, Australia, 5Rush University Medeical Center, Chicago, IL

    Background/Purpose: Cleavage of aggrecan in the interglobular domain (E373-374A) by ADAMTS-4/5 is an early event in osteoarthritis pathogenesis. Further cleavage by MMPs (N341-342F) releases a…
  • Abstract Number: 1019 • 2015 ACR/ARHP Annual Meeting

    Brain Functional Connectivity Differentially Predicts Response to Two Centrally Acting Analgesics in Fibromyalgia

    Eric Ichesco1, Johnson Hampson2, Lynne Pauer3, Andrew Clair4, Tobias Schmidt-Wilcke5, David A. Williams6, Daniel J. Clauw2 and Richard E. Harris1, 1Anesthesiology, U. Michigan, Ann Arbor, MI, 2Anesthesiology, University of Michigan, Ann Arbor, MI, 3Pfizer Inc, New London, CT, 4Pfizer Inc., New York, NY, 5Bergmannsheil, Bochum, Germany, 6Anesthseiology, University of Michigan, Ann Arbor, MI

    Background/Purpose: Recently, several functional brain imaging techniques including functional magnetic resonance imaging (fMRI) have been proposed to be useful in probing the mechanisms of action…
  • Abstract Number: 1020 • 2015 ACR/ARHP Annual Meeting

    Abnormal Resting State Functional Connectivity in Chronic Fatigue Syndrome Patients: An Arterial Spin-Labeling fMRI Study

    Roland Staud1, Song Lai2, Donald Price3, Michael Robinson4, Jason Craggs5 and Jeff Boissoneault6, 1Rheum, Univ of Florida, Gainesville, FL, 2Radiation Oncology, University of Florida, Gainesville, FL, 3Oral Surgery, Univ of Florida, Gainesville, FL, 4Clin and Health Psychology, Univ of Florida, Gainesville, FL, 5Clinical & Health Psychology, University of Missouri, Columbia, MO, 6University of Florida, Gainesville, FL

    Background/Purpose: Myalgic encephalitis/chronic fatigue syndrome (CFS) is a debilitating disorder characterized by disabling fatigue and cognitive dysfunction. However, little is known regarding the neural mechanisms…
  • Abstract Number: 1021 • 2015 ACR/ARHP Annual Meeting

    Nucleic Acids Sensing Receptors RIG-I and MDA5 As Potential Amplifiers of the Interferon Signature in Childhood Onset Systemic Lupus Erythematosus

    Naomi I Maria1, M. Javad Wahadat1, Cornelia G. van Helden-Meeuwsen1, Annette van Dijk-Hummelman2, Radboud JEM Dolhain3, Sylvia Kamphuis2 and Marjan A. Versnel1, 1Immunology, Erasmus Medical Center, Rotterdam, Netherlands, 2Pediatric Rheumatology, Eramus MC Sophia Children's Hospital, Rotterdam, Netherlands, 3Rheumatology, Erasmus Medical Center, Rotterdam, Netherlands

    Background/Purpose: Defective or sustained activation of Interferon (IFN) signaling has been associated with enhanced susceptibility to systemic lupus erythematosus (SLE). The cytosolic RIG-I-like receptors (RLRs),…
  • Abstract Number: 1022 • 2015 ACR/ARHP Annual Meeting

    Identification of Shared Genomic Regions in Distantly Related Pairs of Cases with Juvenile Idiopathic Arthritis

    Sampath Prahalad1, K. Alaine Broadaway2, John F. Bohnsack3, Ann Dodd2, Aimee O. Hersh4, Sheila T. Angeles-Han1, Se Ryeong Jang1, Marc Sudman5, Susan D. Thompson6, Michael Zwick7, Karen Conneely2 and Michael Epstein2, 1Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, 2Emory University School of Medicine, Atlanta, GA, 3Pediatrics, University of Utah Health Sciences Center, Salt Lake City, UT, 4Pediatrics/Rheumatology, University of Utah, Salt Lake City, UT, 5Divison of Rheumatology, Childrens Hospital Med Ctr, Cincinnati, OH, 6Rheumatology Dept, Childrens Hospital Med Ctr, Cincinnati, OH, 7Human Genetics, Emory University School of Medicine, Atlanta, GA

    Background/Purpose: Juvenile idiopathic arthritis (JIA) is a complex genetic trait. While several risk variants have been identified using genome wide studies, a substantial component of…
  • Abstract Number: 1023 • 2015 ACR/ARHP Annual Meeting

    Tumor Necrosis Factor-a (TNF-a) and Interferon Gamma Inducible Protein-10 (IP-10) As Predictors of Active Disease Status in Localized Scleroderma

    Kathryn S. Torok1, Jonathan Yabes2, Qi Mi3, Christina Kelsey1 and Kelsey Magee4, 1Pediatric Rheumatology, Univ of Pittsburgh Med Ctr, Pittsburgh, PA, 2Department of Medicine, University of Pittsburgh, Pittsburgh, PA, 3Department of Sports Medicine and Nutrition, University of Pittsburgh, Pittsburgh, PA, 4Pediatrics, University of Pittsburgh, Pittsburgh, PA

    Background/Purpose:   Localized scleroderma has both inflammatory and fibrotic components contributing to its effect on the skin and underlying tissue.   The extent and duration of…
  • Abstract Number: 1024 • 2015 ACR/ARHP Annual Meeting

    Disruptions in Folate Homeostasis May Lead to Increased Risk for Methotrexate Intolerance in Juvenile Idiopathic Arthritis

    Mara L Becker1, Leon van Haandel2, Ryan Funk3, Rodger Gaedigk4 and J.S. Leeder5, 1Rheumatology, Children's Mercy Kansas City, Kansas City, MO, 2Clinical Pharmacology, Medical Toxicology, and Therapeutic Innovation, Children's Mercy Kansas City, Kansas City, MO, 3University of Kansas Medical Center, Kansas City, KS, 4Clinical Pharmacology, medical Toxicology and Therapeutic Innovation, Children's Mercy Kansas City, Kansas City, MO, 5Clinical Pharmacology, Medical Toxicology and Therapeutic Innovation, Children's Mercy Kansas City, Kansas City, MO

    Background/Purpose: Despite widespread use, there remain no clear predictors of methotrexate (MTX) response or toxicity in Juvenile Idiopathic Arthritis (JIA).  With the utilization of new…
  • Abstract Number: 1025 • 2015 ACR/ARHP Annual Meeting

    Interstitial Lung Disease in Sting-Associated Vasculopathy with Onset in Infancy (SAVI): Genotype-Phenotype Correlation

    Louise Malle1, Bernadette Marrero1, Yin Liu2, Gina A. Montealegre Sanchez1, Dawn C. Chapelle1, Hanna Kim1,3, Michelle O'Brien1, Suzanne Ramsey4, Gregor Dueckers5, Seza Ozen6,7, Helmut Wittkowski8, Dirk Föll9, Klaus Tenbrock10, Olcay Y. Jones11, Steven M. Holland12, Joseph Fontana13, Yan Huang1, Benito Gonzalez14, Paul Brogan15, Juergen Brunner16, Athimalaipet V Ramanan17, Tom Hilliard17, Laisa Santiago18, AnneMarie Brescia19, Amy Paller20, Stephen Brooks21, Zuoming Deng22, Adriana Almeida de Jesus1 and Raphaela Goldbach-Mansky1, 1Translational Autoinflammatory Diseases Section, NIAMS, NIH, Bethesda, MD, 2Scientific Review Branch, NIAMS, NIH, Bethesda, MD, 3Pediatric Rheumatology, Alfred I duPont Hospital for Children, Wilmington, DE, 4Pediatric Rheumatology, IWK Health Centre, Halifax, NS, Canada, 5Helios Kliniken - Kinderklinik, HELIOS Klinikum Krefeld, Krefeld, Germany, 6Paediatric Rheumatology International Trials Organization (PRINTO), Istituto Giannina Gaslini, Genova, Italy, 7Pediatric Nephrology and Rheumatology, Hacettepe University, Ankara, Turkey, Ankara, Turkey, 8Pediatrics, University of Muenster, Muenster, Germany, 9University of Muenster, Muenster, Germany, 10University Aachen, Aachen, Germany, 11Rheumatology, George Washington University, Washington, DC, 12Laboratory of Clinical Infectious Disease, NIAID, NIH, Bethesda, MD, 13NHLBI, NIH, Bethesda, MD, 14Luis Calvo Mackenna Hospital, Santiago, Chile, 15UCL Institute of Child Health and Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom, 16Universitätsklinik für Kinder- u. Jugendheilkunde, Innsbruck, Austria, 17Bristol Royal Hospital for Children, Bristol, United Kingdom, 18All Children's Hospital Rheumatology, Saint Petersburg, FL, 19Jefferson Medical College/ A.I. Dupont Hospital for Children, Willmington, DE, 20Departments of Dermatology and Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA;, Chicago, IL, 21NIAMS/NIH, Bethesda, MD, 22Biodata Mining & Discovery, NIAMS/NIH, Bethesda, MD

    Background/Purpose: STING-Associated Vasculopathy with Onset in Infancy (SAVI) is an IFN-mediated disease caused by gain-of-function mutations in TMEM173, the gene encoding the stimulator of interferon…
  • Abstract Number: 1026 • 2015 ACR/ARHP Annual Meeting

    Microrna-125a-5p Has Increased Expression in Active Systemic Juvenile Idiopathic Arthritis and Is an Essential Modulator of Regulatory Macrophage Phenotypes in Vitro

    Grant Schulert1, Ndate Fall2, Nan Shen3, Sherry Thornton2 and Alexei A. Grom4, 1Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Division of Rheumatology, Cincinnati Children's Hospital, Cincinnati, OH, 3Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

    Background/Purpose: Systemic juvenile idiopathic arthritis (SJIA) is an autoinflammatory disease of childhood, characterized by a predominance of mononuclear phagocytic effector cells, compared to the lymphocyte…
  • Abstract Number: 1027 • 2015 ACR/ARHP Annual Meeting

    Rheumatoid Arthritis Disease Activity Assessment Frequencies in Clinical Practices Do Not Support Treat-to-Target Care

    David Sikes1, James Bower2, Drew Johnson3, J. Timothy Harrington2, Rafia Khalil4, Edmund LaCour5, Michael Naarendorp6, Hillary Norton7 and Kathleen Thomas8, 1Rheumatology, Florida Medical Clinic PA, Zephyrhills, FL, 2Joiner Associates LLC, Madison, WI, 3Crescendo Bioscience, Inc., South San Francisco, CA, 4Rafia Khalil Arthritis & Rheumatology Center, PC, Port Huron, MI, 5Dothan Medical Associates PC, Dothan, AL, 6Harlem Rhematology, LLC, New York, NY, 7Rheumatology, Santa Fe Rheumatology, Santa Fe, NM, 8Community Rheumatology, Noblesville, IN

    Background/Purpose: Treat-to-Target (T2T) recommendations for rheumatoid arthritis (RA) care include standardized frequencies of disease activity (DA) assessment based on DA level. For this study, "on…
  • Abstract Number: 1028 • 2015 ACR/ARHP Annual Meeting

    Improving Pneumococcal Immunization Rates Among Immunocompromised Adolescent Patients at a Tertiary Care Children’s Hospital

    Michal Feldon1, Adam Furnier2, Corinne Lehmann3, Bradford Fletcher4, Jack Kues5, Barbara Speer5, Sandy Kramer6, Pamela Morgan7, Lois Siegle8, Rebecca Brady9 and Jennifer L. Huggins6, 1Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Quality Improvement Systems, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Division of adolescent and transitional medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Division of pharmacy, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 5Continuing medical education department, University of Cincinnati, Cincinnati, OH, 6Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 7Division of gastroenterology, hepatology and nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 8department of gastroenterology, hepatology and nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 9Division of infectious diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

    Background/Purpose: Streptococcus pneumoniae is a leading cause of severe infections, including pneumonia and meningitis, among immunocompromised patients. The administration of both the 13-valent pneumococcal conjugate…
  • Abstract Number: 1029 • 2015 ACR/ARHP Annual Meeting

    Improving Gout Outcomes Using a Disease Management Program within an Integrated Health System

    David Bulbin1, Carson Maynard2, Tarun Sharma1, Alfred E. Denio3, Jason Brown4, Andrea Berger5, H. Lester Kirchner5 and William T. Ayoub6, 1Rheumatology, Geisinger Medical Center, Danville, PA, 2Internal Medicine, Geisinger Medical Center, Danville, PA, 3Dept of Rheumatology, Geisinger Medical Center, Danville, PA, 4Henry Hood Center for Clinical Research, Geisinger Health System, Danville, PA, 5Biostatistics, Geisinger Center for Health Research, Danville, PA, 6Rheumatology, Geisinger Medical Group, State College, PA

    Background/Purpose: Gout is a chronic inflammatory arthritis which can be effectively managed.  The American College of Rheumatology published evidenced based gout management guidelines. These guidelines…
  • « Previous Page
  • 1
  • …
  • 1755
  • 1756
  • 1757
  • 1758
  • 1759
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology